Duquesne Family Office »

Nurix Therapeutics shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2024-09-30 $993k 44k 22.47
2024-06-30 $922k 44k 20.86
2024-03-31 $650k 44k 14.71